ALLERGIC CONJUNCTIVITIS MARKET
The global allergic conjunctivitis market is projected to reach around $2.8 billion by 2026 at a CAGR of approximately 5.6%, from 2018 to 2026.
Allergic conjunctivitis market is growing at a significant rate and more and more providers are emerging to mark their position in the market. The established as well as emerging players are implementing various strategies to develop their business and gain attractive share in this market. Such developments include new product development, mergers, and acquisitions with the global players enabling the companies to enhance their market presence and also increase the competitive scenario in the market.
Some of the major players in the allergic conjunctivitis market include Boehringer Ingelheim GmbH, Allergan Inc., Sanofi-Aventis, Novartis AG, Bausch & Lomb Inc., CIBA Vision Ophthalmics, Pfizer Inc., Merck & Co., Inc., and Santen Pharmaceuticals Co. Ltd.
Allergic conjunctivitis is inflammation of the conjunctiva (the membrane covering the white part of the eye) due to allergy. Conjunctivitis is one of the most common and treatable eye conditions in children and adults. Although allergens differ among patients, the most common cause is hay fever. Symptoms consist of redness (mainly due to vasodilation of the peripheral small blood vessels), brning feeling, Swollen eyelids, itching, and increased lacrimation (production of tears). If this is combined with rhinitis, the condition is termed allergic rhino conjunctivitis. The symptoms are due to release of histamine and other active substances by mast cells, which stimulate dilation of blood vessels, irritate nerve endings, and increase secretion of tears.
Enhanced awareness about allergic conjunctivitis among the patients, medical community and people associated with the patients is one of the major driver for the growth of global allergic conjunctivitis market. Development in lifestyle and overall growth in number of patients suffering from allergic conjunctivitis are key factors boosting the growth of the global allergic conjunctivitis market. Hence, treatments that can reduce allergic conjunctivitis are in demand. However, high cost associated with clinical trials acts as a major barrier for global allergic conjunctivitis market.
Market Dynamics: Drivers, Restraints, Opportunities Challenges
- Allergic Conjunctivitis Pipe Line Drugs are Key Strength for this Market Place
In the global allergic conjunctivitis market, allergic conjunctivitis pipe line drugs will play the major role for the growth of this market. At present several drugs such as Zerviate, OTX-DP, ADX-102, PRT-2761, CVXL-0074, AK-002, Bertilimumab, Reproxalap, ST-266, SYL-116011 etc. are in preclinical, IND, Phase I, Phase II and Phase III stage.
- Increasing prevalence of various allergic conjunctivitis
Allergic conjunctivitis is a critical public health, medical and economic problem globally. It is also an important risk factor which will cause many diseases or disorders. Allergic conjunctivitis is one of the most common chronic diseases in all age groups. The trend of AR incidence is still on the rise in recent years and has had a significant effect on the general public. This significant increase is alarming, which highlights an urgent need for better understanding of the prevalence status and characteristics, sensitization patterns, and the associated risk factors in order to improve treatment and develop effective prevention strategies.
Allergic Conjunctivitis Market by Disease Type
- Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC)
- Vernal Keratoconjunctivitis (VKC)
- Atopic Keratoconjunctivitis (AKC)
- Giant Papillary Conjunctivitis (GPC)
Allergic Conjunctivitis Market by Treatment
- Allergy shots (immunotherapy)
Allergic Conjunctivitis Market by End Users
- Medical Institute
- Eye Hospitals
- Research Centers
- North America dominates the global allergic conjunctivitis market followed by Europe.
In, 2018 North America was the dominant area in global allergic conjunctivitis market. Rising awareness about health and strong healthcare support systems in this region has made it the largest allergic conjunctivitis market. However, rising disposable income and increasing large patient population in emerging economies such as India and China are expected to play a significant role in the expansion of this industry over the estimate period.
Hence, rapid technological advancement, increase in the number of patients, increasing aging population, increasing demand for efficient drug types, increase in the incidence and prevalence of allergic conjunctivitis cases is expected to fuel growth of the global allergic conjunctivitis market during forecast period.
Table of Content
- Research Methodology
- Executive Summary
- Market Overview
- Industry Insights
- Allergic Conjunctivitis Market, by Disease Type
- Allergic Conjunctivitis Market, by Treatment
- Allergic Conjunctivitis Market, by End Users
- Allergic Conjunctivitis Market, by Region
- Competitive Landscape
- Company Profiles
Read Other Reports from our Database :
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.
Ph: +162 825 80070 (US)
Ph: +44 203 500 2763 (UK)